10 min

Repurposing rheumatology drugs for COVID-19: JAK inhibitors Medicine Matters rheumatology

    • Medicine

Marwan Bukhari talks about the rationale behind investigating baricitinib and other JAK inhibitors for the treatment of COVID-19 and outlines the current efficacy data.

  • Springer Healthcare, part of the Springer Nature group

Marwan Bukhari talks about the rationale behind investigating baricitinib and other JAK inhibitors for the treatment of COVID-19 and outlines the current efficacy data.

10 min

  • Springer Healthcare, part of the Springer Nature group